Some email communications may be filtered to your Spam or Junk folder, even if you have subscribed to them. Please mark aaciupdate@aaci-cancer.ccsend.com as a Safe Sender to ensure that AACI emails are delivered to your inbox.
| | |
AACI is pleased to announce that UMass Memorial Health (UMMH) Cancer Center became the association's newest member in December 2025. UMMH Cancer Center is led by David Cachia, MD, interim chief of Hematology Oncology Services and associate professor of neuro-oncology at the University of Massachusetts. Read More
| | |
The AACI Clinical Research Innovation (CRI) Steering Committee is currently soliciting abstracts for the 18th Annual AACI CRI Meeting. This year’s meeting theme is "Shaping the Future of Clinical Trial Innovation." The purpose of the abstracts is to inform attendees about challenges and solutions implemented at AACI cancer centers, showcasing advancements across key areas in clinical research and operational excellence. Read More
| | |
"Bringing Data and People Together in Clinical Research" will focus on practical ways to use catchment area data to ensure that clinical trial enrollment reflects both the broader population and specific neighborhoods. The session is scheduled for 9:00 am eastern time on Wednesday, March 11. Read More | Register for the 2026 AACI CADEx Conference
| | AACI invites you to promote your cancer center or company by purchasing an ad in the AACI Update. Your ad may highlight a conference, new initiative, or product of interest to AACI members. In addition to newsletter ads, AACI offers a variety of support opportunities for its annual events. For more information about supporting AACI, please contact Development Manager Chelsea Borries. Read More | | AACI is pleased to announce the launch of a new Cancer Service Line listserv. This new platform offers an additional space for members to connect, share best practices, and exchange insights. All AACI members who work with service lines are welcome to participate. Subscribers must have a valid cancer center email address to join. Read More | | |
Armando E. Giuliano, MD, received the William L. McGuire Memorial Lecture Award in December at the San Antonio Breast Cancer Symposium, in recognition of his development of the sentinel lymph node technique, transforming surgical management of breast cancer. Read More
| | |
Mark R. Kelley, PhD, senior leader for biomedical innovation and partnerships at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, has been named a 2025 fellow of the National Academy of Inventors for his contributions to pediatrics and cancer research. Read More
| | |
Edna "Eti" Cukierman, PhD, was recently appointed to the National Cancer Institute’s Working Group for Extramural Research Concepts, an advisory group that brings together 35 national experts to help shape the direction of federally supported cancer research. Read More
| | The University of Kansas Medical Center, Children’s Mercy, and the University of Kansas Health System have collectively been designated a NORD Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The NORD Rare Disease Centers of Excellence Network now includes 46 institutions across 28 states and Washington, DC. Read More | | |
Dennis Slamon, MD, PhD, whose innovations in breast cancer treatment have benefited millions around the globe, was named to the 2025 class of the National Academy of Inventors. Read More
| | |
Armin Ghobadi, MD, a WashU Medicine professor of medicine and bone marrow transplant specialist, has been named director of cellular therapies at Siteman Cancer Center. The new position formalizes his role as leader of clinical care and clinical research activities related to cellular therapy in the Hematologic Malignancies program at WashU Medicine. Read More
| | |
Kathleen Goss, PhD, has been named executive director of cancer research administration for UChicago Medicine Comprehensive Cancer Center, effective January 5. She most recently served as senior scientific director for extramural discovery science at the American Cancer Society. Read More
| | |
The University of Michigan Rogel Cancer Center has named Christopher J. Liekweg, MBA, CMPE, associate director for administration and chief department administrator, effective January 12. Liekweg is a senior administrator at VCU Health, the academic medical center of Virginia Commonwealth University. He was previously executive director for radiation oncology at the University of Louisville. Read More
| | The transition to adult care may get easier for childhood cancer survivors at The University of Kansas Cancer Center, thanks to a $750,000 grant from Braden’s Hope for Childhood Cancer, a Kansas City-based nonprofit organization founded to accelerate the fight against childhood cancer. The award will fund a new Adolescent and Young Adult Cancer Transitions Program at KU Cancer Center. Read More | | |
Christopher G. Cann, MD, first found his passion for treating young adult cancer patients as a resident and fellow. Now, after receiving the Robert A. Winn Excellence in Clinical Trials: Career Development Award, he is even better equipped to work with this unique, underserved population. Read More
| | | | |
PO Box 7317
Pittsburgh, PA 15213
| | | | | |
